2021
DOI: 10.1158/1078-0432.ccr-20-2017
|View full text |Cite
|
Sign up to set email alerts
|

Discrimination of Breast Cancer from Healthy Breast Tissue Using a Three-component Diffusion-weighted MRI Model

Abstract: Competing Interest Statement Dr. Dale reports that he was a Founder of and holds equity in CorTechs Labs, Inc., and serves on its Scientific Advisory Board. He is a member of the Scientific Advisory Board of Human Longevity, Inc. He receives funding through research grants from GE Healthcare to UCSD. Dr. Rakow-Penner is a consultant for Human Longevity, Inc. and receives funding through research grants from GE Healthcare. The terms of these arrangements have been reviewed by and approved by UCSD in accordance … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
32
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(33 citation statements)
references
References 51 publications
1
32
0
Order By: Relevance
“…Combination of multiple RSI outputs is ongoing work in our laboratory and has shown potential for accurate automatic classification of breast lesions. 49 Future work includes the use of RSI-derived signal contributions and advanced computer algorithms to evaluate the diagnostic value of multi-exponential models in an independent cohort. Altogether, these data may be used to aid in radiological differentiation between benign tissues and malignant breast lesions without the use of intravenous contrast agents.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Combination of multiple RSI outputs is ongoing work in our laboratory and has shown potential for accurate automatic classification of breast lesions. 49 Future work includes the use of RSI-derived signal contributions and advanced computer algorithms to evaluate the diagnostic value of multi-exponential models in an independent cohort. Altogether, these data may be used to aid in radiological differentiation between benign tissues and malignant breast lesions without the use of intravenous contrast agents.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the plots from biexponential and 3‐component models in Figure 2B, it becomes evident that C 1,3 has a higher tumor conspicuity compared to C 2,3 . Combination of multiple RSI outputs is ongoing work in our laboratory and has shown potential for accurate automatic classification of breast lesions 49 . Future work includes the use of RSI‐derived signal contributions and advanced computer algorithms to evaluate the diagnostic value of multi‐exponential models in an independent cohort.…”
Section: Discussionmentioning
confidence: 99%
“…Magnetic resonance imaging (MRI) is widely used for evaluating breast cancer because of its non-invasive nature and excellent soft tissue contrast (1)(2)(3)(4). Particularly, single diffusion encoding along a single direction per shot has been incorporated as a key imaging technique into routine breast MRI examination to complement dynamic contrastenhanced (DCE) MRI, since single diffusion encoding can produce contrast in tissues without using gadolinium contrast medium injections and images can be acquired rapidly (5)(6)(7)(8).…”
Section: Introductionmentioning
confidence: 99%
“…[14][15][16] A recent trend to utilize gadolinium-free MRI techniques in clinical scenarios where use of GBCA is a challenge, like pregnancy, severe contrast allergies, and lactational status [17][18][19] rely on Diffusion-(GBCA-free)-MRI techniques (DWI/DTI-MRI) that are based on the intrinsic cellular contrast. [20][21][22][23][24][25][26] Certain breast Diffusion-MRI protocols have also been used for high-risk screening and as a problem-solving tool in selected cases, 27,28 however it should not be used as stand-alone technique yet, as clinical protocols are still under evaluation. 29,30 This review provides considerations that may be helpful for clinical practice of both general MRI and breast subspecialty radiologists.…”
mentioning
confidence: 99%